Showing 1–16 of 32 results
-
Abnormal 1 Reference Control
Controls & Specialty Plasmas
CRYOcheckâ„¢ Abnormal 1 Reference Control is intended for use as an assayed borderline abnormal control for parameters listed on the Assay Certificate. Reference values are assigned by an independent, internationally-recognized reference laboratory, using international reference standards (where available).
- 8-hour stability once thawed if refrigerated at 2 °C to 8 °C in the original capped vial
- Source plasmas are screened negative for all FDA-required tests
-
Abnormal 2 Reference Control (25 x 1.0 mL)
Controls & Specialty Plasmas
CRYOcheckâ„¢ Abnormal 2 Reference Control is intended for use as an assayed pathological abnormal control for parameters listed on the Assay Certificate. Reference values are assigned by an independent, internationally-recognized reference laboratory, using international reference standards (where available).
- 8-hour stability once thawed if refrigerated at 2 °C to 8 °C in the original capped vial
- Source plasmas are screened negative for all FDA-required tests
-
Blood Transfusion Set, Non-Vented, for Gemini/Alaris Pump module
$799.00Brand: CareFusion
Administration sets for use with the Gemini/Alaris Pump module. Contains an integrated safety clamp fitment to help prevent accidental free flow.
- 180micron filter.
- SmartSite needle-free valve.
- Two piece male luer lock.
- 15 Drop.
- Latex-Free.
Additional Information:
- Latex content: Latex-Free
- Feature / Property: 180Micron Filter, Non-Vented, SmartSite Needle-Free Valve, Two Piece Male Luer Lock, For GEMINI/Alaris Series Pump
- Length: 122″
-
Chromogenic Factor VIII
Diagnostic Kits
CRYOcheck™ Chromogenic Factor VIII is a chromogenic assay for the determination of factor VIII activity in human plasma. It is intended to be used as an aid in the management of hemophilia A in individuals aged two years or older. With a limit of quantification of 0.5% FVIII activity and a test range of 0–200% FVIII using one standard curve*, CRYOcheck Chromogenic Factor VIII provides unsurpassed assurance in results, especially in cases of patients with severe hemophilia A.
With the ability to store thawed reagents at 2 to 8°C for up to five days, or refreeze for up to one month, labs of all sizes can meet their testing requirements while minimizing wastage.
- Convenient frozen format ready to use within minutes, no reconstitution errors
- Intended for use on automated coagulation analyzers
- Only one calibration curve used for entire measuring range of 0–200%*
- 8-hour on-board stability
- Contains bovine based factor X reagent
* may vary based on the instrumentation in use
-
HIV 1/2 Confirmatory Controls
Controls intended for monitoring system performance of the Geenius HIV 1/2 Confirmatory Assay (120 µl x 2)
SKU: 72329
1x Geeniusâ„¢ HIV 1/2 Confirmatory Controls – Negative Control, 120 µL
1x Geeniusâ„¢ HIV 1/2 Confirmatory Controls – Positive Control, 120µL
-
iQâ„¢ Supermix
$1,456.00iQ Supermix is specially formulated for real-time PCR and has been tested for reliable amplification over a wide dynamic range of human genomic and plasmid DNA concentrations. It contains hot-start iTaq DNA Polymerase, dNTPs qualified for quantitative PCR, and buffer at concentrations optimal for real-time PCR assays. iQ Supermix facilitates reaction optimization and is qualified for use with all Bio-Rad real-time detection systems.
Key Features:
Increased throughput; only template, primers, and probes are needed
Convenient reaction assembly at room temperature
Easy-to-use formulation minimizes contaminationApplications and Uses:
PCR and real-time PCR analysis
Gene expression analysis
Genotyping studies
Genomics-related applicationsPackage Size: 500 x 50 µl reactions, 2x real-time PCR mix, contains dNTPs, 6 mM MgCl2, 50 U/ml hot-start iTaq™ DNA polymerase
-
Legionella Urinary Antigen Card (22 test kit)
BinaxNOW™ Legionella Urinary Antigen Card is a rapid assay for the qualitative detection of Legionella pneumophila serogroup 1 antigen in urine samples from patients with symptoms of pneumonia. It is intended to aid in the presumptive diagnosis of Legionnaires’ disease caused by L. pneumophila serogroup 1 in conjunction with culture and other methods.
-
Lupus Negative Control
Controls & Specialty Plasmas
CRYOcheckâ„¢ Lupus Negative Control is intended for use as a negative control in assays for lupus anticoagulant (LA). It contains citrated human plasma collected from donors that have tested negative in accordance with the revised criteria of the SSC Subcommittee for the Standardization of Lupus Anticoagulants.
- 8-hour stability once thawed if refrigerated at 2 °C to 8 °C in the original capped vial
- Source plasmas are screened negative for all FDA-required tests
-
Malaria Positive Control (10 tests/package)
The BinaxNOW™ Malaria test is an in vitro immunochromatographic assay for the qualitative detection of Plasmodium antigens circulating in human venous and capillary EDTA whole blood of individuals with signs and symptoms of malarial infection. The test targets the histidine-rich protein II (HRPII) antigen specific to Plasmodium falciparum (P.f.) and a pan-malarial antigen common to all four malaria species capable of infecting humans - P. falciparum, P. vivax (P.v.), P. ovale (P.o.), and P. malariae (P.m.).
It is intended to aid in the rapid diagnosis of human malaria infections and in the differential diagnosis of Plasmodium falciparum (P.f.) infections from other less virulent malarial infections. Negative results must be confirmed by thin / thick smear microscopy.
-
Malaria test (25 tests/package)
The BinaxNOW™ Malaria test is an in vitro immunochromatographic assay for the qualitative detection of Plasmodium antigens circulating in human venous and capillary EDTA whole blood of individuals with signs and symptoms of malarial infection. The test targets the histidine-rich protein II (HRPII) antigen specific to Plasmodium falciparum (P.f.) and a pan-malarial antigen common to all four malaria species capable of infecting humans - P. falciparum, P. vivax (P.v.), P. ovale (P.o.), and P. malariae (P.m.).
It is intended to aid in the rapid diagnosis of human malaria infections and in the differential diagnosis of Plasmodium falciparum (P.f.) infections from other less virulent malarial infections. Negative results must be confirmed by thin / thick smear microscopy.